| New data for linagliptin* show clinically meaningful efficacy similar to ... - Financial Post |
|
|
Financial Post 2 Linagliptin was also evaluated in T2D patients with different degrees of renal function. 3 A large pooled analysis of three randomised, placebo-controlled Phase III trials (n=2141) showed that patients who received linagliptin had HbA1c reductions |